FENC [NASD]
Fennec Pharmaceuticals Inc.
Index- P/E- EPS (ttm)-0.63 Insider Own0.10% Shs Outstand26.02M Perf Week5.07%
Market Cap150.97M Forward P/E156.76 EPS next Y0.04 Insider Trans0.00% Shs Float21.61M Perf Month-3.01%
Income-16.30M PEG- EPS next Q-0.12 Inst Own44.00% Short Float1.23% Perf Quarter19.10%
Sales- P/S- EPS this Y12.70% Inst Trans0.79% Short Ratio7.41 Perf Half Y-41.12%
Book/sh0.48 P/B12.08 EPS next Y100.00% ROA-68.20% Target Price11.20 Perf Year-14.45%
Cash/sh0.70 P/C8.25 EPS next 5Y- ROE-93.70% 52W Range3.82 - 10.08 Perf YTD31.82%
Dividend- P/FCF- EPS past 5Y-25.00% ROI- 52W High-44.24% Beta-0.06
Dividend %- Quick Ratio9.00 Sales past 5Y- Gross Margin- 52W Low47.05% ATR0.37
Employees10 Current Ratio9.00 Sales Q/Q- Oper. Margin- RSI (14)45.87 Volatility5.19% 7.12%
OptionableYes Debt/Eq0.40 EPS Q/Q22.00% Profit Margin- Rel Volume0.86 Prev Close5.80
ShortableYes LT Debt/Eq0.36 EarningsMay 12 BMO Payout- Avg Volume35.81K Price5.62
Recom2.00 SMA20-3.41% SMA50-3.98% SMA200-14.15% Volume10,071 Change-3.10%
Jun-05-20Initiated Cantor Fitzgerald Overweight $18
Oct-11-18Initiated Goldman Buy
May-23-22 07:29AM  
May-12-22 06:00AM  
May-06-22 05:17PM  
May-03-22 09:55AM  
Apr-27-22 06:00AM  
Mar-25-22 07:00AM  
Mar-24-22 06:00AM  
Feb-28-22 06:00AM  
Jan-31-22 06:00AM  
Jan-27-22 05:38PM  
Dec-14-21 07:50PM  
Dec-13-21 10:08AM  
Dec-01-21 07:06AM  
Nov-30-21 04:20PM  
10:57AM  
06:00AM  
05:49AM  
Nov-29-21 07:23PM  
07:24AM  
06:00AM  
Nov-10-21 06:00AM  
Oct-05-21 08:30AM  
Sep-29-21 02:27PM  
Sep-09-21 06:00AM  
Aug-10-21 06:00AM  
Aug-02-21 03:18AM  
Jun-29-21 05:30PM  
Jun-24-21 06:00AM  
Jun-22-21 07:17AM  
06:00AM  
Jun-03-21 03:33AM  
May-28-21 06:00AM  
May-13-21 06:00AM  
Apr-04-21 05:54AM  
Mar-30-21 06:00AM  
Feb-03-21 01:59AM  
Dec-09-20 07:51AM  
Dec-02-20 11:27PM  
Nov-27-20 10:27AM  
Nov-19-20 10:02AM  
Nov-16-20 07:02AM  
Nov-05-20 07:46AM  
Nov-02-20 03:57PM  
02:30PM  
01:10PM  
11:29AM  
10:00AM  
09:15AM  
09:00AM  
08:00AM  
06:30AM  
12:15AM  
Nov-01-20 03:46PM  
Oct-30-20 09:00PM  
08:05PM  
06:45PM  
02:45PM  
12:00PM  
11:40AM  
11:01AM  
11:00AM  
09:35AM  
Oct-29-20 09:22PM  
07:55PM  
12:00PM  
11:30AM  
11:12AM  
11:00AM  
10:40AM  
09:38AM  
Oct-28-20 09:39PM  
08:00PM  
07:15PM  
02:27PM  
01:00PM  
01:00PM  
12:30PM  
11:45AM  
11:00AM  
10:20AM  
09:57AM  
Oct-27-20 12:00PM  
11:10AM  
11:00AM  
10:00AM  
09:57AM  
09:26AM  
Oct-26-20 05:24PM  
03:50PM  
12:55PM  
12:30PM  
11:45AM  
11:00AM  
11:00AM  
10:26AM  
Oct-23-20 07:10PM  
06:30PM  
04:55PM  
04:10PM  
10:40AM  
Fennec Pharmaceuticals Inc., a biopharmaceutical company, develops product candidates for use in the treatment of cancer in the United States. Its lead product PEDMARK, a formulation of Sodium Thiosulfate that has completed the Phase III clinical trial for the prevention of cisplatin induced hearing loss or ototoxicity in children. The company was formerly known as Adherex Technologies Inc. and changed its name to Fennec Pharmaceuticals Inc. in September 2014. Fennec Pharmaceuticals Inc. was incorporated in 1996 and is based in Research Triangle Park, North Carolina.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
RALLIS CHRIS ADirectorMar 08Option Exercise0.5717,59210,00020,925Mar 08 08:24 AM
RALLIS CHRIS ADirectorOct 21Option Exercise1.503,3335,0003,333Oct 21 03:40 PM